サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1428167

単細胞オミックスの世界市場レポート 2024

Single-Cell Omics Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
単細胞オミックスの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

単細胞オミックスの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には16.2%の年間複合成長率（CAGR）で38億4,000万米ドルに成長すると予想されます。臨床診断における単細胞オミックスの採用の増加、マルチオミクスアプローチへの統合、再生医療、創薬、細胞療法、免疫療法などの分野での応用により、予測期間の成長が見込まれると予想されます。この期間に予測される主要な動向には、イン・ビボ単細胞研究の台頭、感染症調査における単細胞オミックスの使用拡大、マイクロ流体工学と単細胞選別技術の進歩、単細胞レベルでの複数のオミクスデータの統合、そして空間的単一細胞プロファイリング技術の開発。これらの動向は業界の情勢を形成し、次の予測期間における成長を促進すると予想されます。

がん罹患率の予想される増加は、単細胞オミックス市場の成長に大きく貢献すると予想されます。制御されていない細胞の増殖と浸潤を特徴とするさまざまな病気を含むがんは、単細胞オミックスアプリケーションにとって重要な焦点です。 単細胞オミックスデータの利用は、がん診断のためのバイオマーカーの特定、予後の予測、および所定の臨床コホート内の新規治療標的の発見において極めて重要な役割を果たします。米国がん協会は、2023年に米国で新たにがんと診断される患者数は190万人になると予想され、2020年に新たにがんと診断される患者数180万人と比較して増加すると報告しました。このがん有病率の上昇が、単細胞オミックス市場の成長を牽引する力となっています。

臨床試験の数の増加も、単細胞オミックス市場の成長を促進すると予想されます。医療介入、治療法、薬剤の安全性と有効性を評価するためにヒトを対象に実施される重要な調査である臨床試験は、大幅な増加を見せています。臨床試験で単細胞オミックスを適用すると、個々の細胞の詳細な分析が容易になり、細胞の不均一性に関する貴重な洞察が得られ、精密医療アプローチが強化されます。 2023年 5月17日の時点で、ClinicalTrials.govには世界中で452,604件の臨床試験が登録されているとXtalksが報告しました。これは、2021年初頭に報告された365,000件以上の登録臨床試験から大幅に増加しています。この臨床試験の急増が単細胞オミックスマーケットの成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の単細胞オミックス市場促進要因と制約要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の単細胞オミックスの市場規模実績と成長、2018年から2023年
  • 世界の単細胞オミックス市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の単細胞オミックス市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 単細胞ゲノミクス
  • 単細胞トランスクリプトミクス
  • 単細胞プロテオミクス
  • 単細胞メタボロミクス
  • 世界の単細胞オミックス市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 細胞分離技術
  • サンプル調製技術
  • 次世代シーケンスの解析
  • 世界の単細胞オミックス市場、アプリケーション別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 腫瘍学
  • 細胞生物学
  • 神経内科
  • 免疫学
  • 世界の単細胞オミックス市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 製薬会社およびバイオテクノロジー会社
  • 学術および調査機関
  • 病院および診断研究所
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の単細胞オミックス市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の単細胞オミックス市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 単細胞オミックス市場の競合情勢
  • 単細胞オミックス市場の企業プロファイル
    • Danaher Corporation
    • Merck KGaA
    • Becton Dickinson and Company
    • GE HealthCare Technologies Inc.
    • Thermo Fischer Scientific Inc.

第31章 その他の大手および革新的な企業

  • Agilent Technologies Inc.
  • Sartorius AG
  • Illumina Inc.
  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • DiaSorin SpA
  • Tecan Group Ltd.
  • BGI Genomics Co. Ltd.
  • Promega Corporation
  • 10x Genomics Inc.
  • Takara Bio Inc.
  • NanoString Technologies Inc.
  • Vizgen
  • HiFiBiO Therapeutics

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14011

Single-cell omics refers to the analysis and profiling of individual cells obtained from diverse populations, enabling the examination and understanding of both healthy and diseased cellular processes at a granular, single-cell level. This approach is instrumental in studying cellular heterogeneity, identifying cell types, conducting disease research, and developing therapeutic interventions.

The primary types of single-cell omics products encompass single-cell genomics, single-cell transcriptomics, single-cell proteomics, and single-cell metabolomics. Single-cell genomics, for instance, is an advanced technique used to classify individual cells, identifying unique cell types and characterizing distinct cellular features. Various technologies are employed in single-cell omics, including cell isolation and sample preparation methods, as well as next-generation sequencing analysis. These technologies find application across diverse fields such as oncology, cell biology, neurology, immunology, and others. End users of single-cell omics products include pharmaceutical and biotechnology companies, academic and research institutions, hospital and diagnostic laboratories, and other relevant entities involved in advancing scientific research and medical applications.

The single-cell omics market research report is one of a series of new reports from The Business Research Company that provides single-cell omics market statistics, including single-cell omics industry global market size, regional shares, competitors with a single-cell omics market share, detailed single-cell omics market segments, market trends and opportunities, and any further data you may need to thrive in the single-cell omics industry. This single-cell omics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The single-cell omics market size has grown rapidly in recent years. It will grow from $1.81 billion in 2023 to $2.1 billion in 2024 at a compound annual growth rate (CAGR) of 16.3%. The growth observed in the historic period within the field of single-cell omics can be attributed to several key factors. These include the discovery and understanding of cellular heterogeneity, advancements in the development and emergence of tools for single-cell analysis, progress in biomedical research, in-depth characterization of the immune system at the single-cell level, and the increasing prominence of precision medicine approaches. These factors collectively contributed to the growth and expansion of single-cell omics during the historic period by fostering a deeper comprehension of cellular diversity, providing innovative tools for analyzing individual cells, furthering biomedical research endeavors, enabling comprehensive insights into the immune system, and promoting the evolution of personalized approaches in medical treatments through precision medicine.

The single-cell omics market size is expected to see rapid growth in the next few years. It will grow to $3.84 billion in 2028 at a compound annual growth rate (CAGR) of 16.2%. Anticipated growth in the forecast period is expected due to increased adoption of single-cell omics in clinical diagnostics, its integration into multi-omics approaches, and its application in areas such as regenerative medicine, drug development, cellular therapies, and immunotherapies. Key trends projected for this period involve the rise of in vivo single-cell studies, the expanded use of single-cell omics in infectious disease research, advancements in microfluidics and single-cell sorting technologies, the integration of multiple omics data at the single-cell level, and the development of spatial single-cell profiling techniques. These trends are expected to shape the landscape of the industry and drive its growth in the coming forecasted period.

The anticipated rise in the prevalence of cancer is expected to significantly contribute to the growth of the single-cell omics market. Cancer, encompassing a range of illnesses characterized by uncontrolled cell proliferation and invasion, is a crucial focus for single-cell omics applications. The utilization of single-cell omics data plays a pivotal role in identifying biomarkers for cancer diagnosis, predicting prognosis, and discovering novel therapeutic targets within predetermined clinical cohorts. In 2023, the American Cancer Society Inc. reported that the expected number of new cancer cases in the United States is 1.9 million, marking an increase compared to the 1.8 million new cancer cases diagnosed in 2020. This rising prevalence of cancer serves as a driving force behind the growth of the single-cell omics market.

The increasing number of clinical trials is also expected to propel the growth of the single-cell omics market. Clinical trials, essential research studies conducted on human subjects to evaluate the safety and efficacy of medical interventions, treatments, or drugs, have seen a substantial surge. The application of single-cell omics in clinical trials facilitates detailed analyses of individual cells, offering valuable insights into cellular heterogeneity and enhancing precision medicine approaches. As of May 17, 2023, Xtalks reported that there are 452,604 registered clinical trials globally on ClinicalTrials.gov, representing a significant increase from the over 365,000 registered trials reported in early 2021. This surge in clinical trials serves as a driving factor for the growth of the single-cell omics market.

Product innovation stands out as a pivotal trend gaining traction in the single-cell omics market, with major companies actively pursuing the development of cutting-edge products to maintain their market positions. A notable example is Deepcell, a US-based software provider specializing in single-cell dimensional morphology analysis, which, in May 2023, introduced the REM-I Platform. This platform represents a scalable solution for single-cell imaging, high-dimensional analysis, and cell sorting, providing unprecedented insights into cell biology. The REM-I Platform is poised to catalyze new discoveries across various domains, including cancer biology, developmental biology, stem cell biology, gene therapy, and functional screening. Its unique combination of single-cell imaging, sorting, and high-dimensional analysis is expected to open new avenues for exploration and research.

Major companies in the single-cell omics market are concentrating on the development of advanced kits tailored for single-cell applications to drive market revenues. Sequencing kits, pre-packaged sets of reagents and materials designed for genetic sequencing processes, play a crucial role in streamlining laboratory workflows. Singular Genomics Systems, Inc., a US-based company specializing in novel next-generation sequencing, exemplifies this trend. In February 2023, the company launched the Max Read Kits for single-cell sequencing on the G4 Sequencing Platform. These kits, compatible with popular 10x Genomics assays, offer flexibility for sequencing 4 to 16 samples per run. The Max Read Kits deliver 800 million reads per flow cell with 80% to 90% Q30 quality. Singular Genomics has also elevated the quality specifications of the G4 Sequencing Platform's F2 and F3 flow cells, achieving up to 1.8 billion reads per run on the F3 flow cells for select applications. This strategic focus on advanced sequencing kits aligns with the industry's commitment to enhancing efficiency and precision in single-cell omics applications.

In March 2022, Singleron Biotechnologies, a genomics company based in China, successfully acquired Proteona Pte. Ltd for an undisclosed sum. This strategic acquisition was driven by Singleron's objective to extend its global footprint and gain access to Proteona's cutting-edge technologies specialized in single-cell multi-omic analysis. Proteona, headquartered in Singapore, is a precision medicine firm recognized for its proficiency in single-cell proteogenomic analysis.

Major companies operating in the single-cell omics market report are Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

North America was the largest region in the single-cell omics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the single-cell omics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The single-cell omics market includes revenues earned by entities through single-cell sorting and isolation, single-cell sample preparation kits, and related single-cell data analysis software. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Single-Cell Omics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on single-cell omics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for single-cell omics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The single-cell omics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Single-Cell Genomics; Single-Cell Transcriptomics; Single-Cell Proteomics; Single-Cell Metabolomics
  • 2) By Technology: Cell Isolation Technologies; Sample Preparation Technologies; Analysis Of Next-Generation Sequencing
  • 3) By Application: Oncology; Cell Biology; Neurology; Immunology
  • 4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Organizations; Hospital And Diagnostic Laboratories; Other End Users
  • Companies Mentioned: Danaher Corporation; Merck KGaA; Becton Dickinson and Company; GE HealthCare Technologies Inc.; Thermo Fischer Scientific Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Single-Cell Omics Market Characteristics

3. Single-Cell Omics Market Trends And Strategies

4. Single-Cell Omics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Single-Cell Omics Market Size and Growth

  • 5.1. Global Single-Cell Omics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Single-Cell Omics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Single-Cell Omics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Single-Cell Omics Market Segmentation

  • 6.1. Global Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Single-Cell Genomics
  • Single-Cell Transcriptomics
  • Single-Cell Proteomics
  • Single-Cell Metabolomics
  • 6.2. Global Single-Cell Omics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cell Isolation Technologies
  • Sample Preparation Technologies
  • Analysis Of Next-Generation Sequencing
  • 6.3. Global Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Cell Biology
  • Neurology
  • Immunology
  • 6.4. Global Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Academic And Research Organizations
  • Hospital And Diagnostic Laboratories
  • Other End Users

7. Single-Cell Omics Market Regional And Country Analysis

  • 7.1. Global Single-Cell Omics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Single-Cell Omics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Single-Cell Omics Market

  • 8.1. Asia-Pacific Single-Cell Omics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Single-Cell Omics Market

  • 9.1. China Single-Cell Omics Market Overview
  • 9.2. China Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Single-Cell Omics Market

  • 10.1. India Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Single-Cell Omics Market

  • 11.1. Japan Single-Cell Omics Market Overview
  • 11.2. Japan Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Single-Cell Omics Market

  • 12.1. Australia Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Single-Cell Omics Market

  • 13.1. Indonesia Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Single-Cell Omics Market

  • 14.1. South Korea Single-Cell Omics Market Overview
  • 14.2. South Korea Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Single-Cell Omics Market

  • 15.1. Western Europe Single-Cell Omics Market Overview
  • 15.2. Western Europe Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Single-Cell Omics Market

  • 16.1. UK Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Single-Cell Omics Market

  • 17.1. Germany Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Single-Cell Omics Market

  • 18.1. France Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Single-Cell Omics Market

  • 19.1. Italy Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Single-Cell Omics Market

  • 20.1. Spain Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Single-Cell Omics Market

  • 21.1. Eastern Europe Single-Cell Omics Market Overview
  • 21.2. Eastern Europe Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Single-Cell Omics Market

  • 22.1. Russia Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Single-Cell Omics Market

  • 23.1. North America Single-Cell Omics Market Overview
  • 23.2. North America Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Single-Cell Omics Market

  • 24.1. USA Single-Cell Omics Market Overview
  • 24.2. USA Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Single-Cell Omics Market

  • 25.1. Canada Single-Cell Omics Market Overview
  • 25.2. Canada Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Single-Cell Omics Market

  • 26.1. South America Single-Cell Omics Market Overview
  • 26.2. South America Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Single-Cell Omics Market

  • 27.1. Brazil Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Single-Cell Omics Market

  • 28.1. Middle East Single-Cell Omics Market Overview
  • 28.2. Middle East Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Single-Cell Omics Market

  • 29.1. Africa Single-Cell Omics Market Overview
  • 29.2. Africa Single-Cell Omics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Single-Cell Omics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Single-Cell Omics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Single-Cell Omics Market Competitive Landscape And Company Profiles

  • 30.1. Single-Cell Omics Market Competitive Landscape
  • 30.2. Single-Cell Omics Market Company Profiles
    • 30.2.1. Danaher Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Merck KGaA
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Becton Dickinson and Company
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. GE HealthCare Technologies Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Thermo Fischer Scientific Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Single-Cell Omics Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Sartorius AG
  • 31.3. Illumina Inc.
  • 31.4. PerkinElmer Inc.
  • 31.5. Bio-Rad Laboratories Inc.
  • 31.6. Qiagen N.V
  • 31.7. DiaSorin S.p.A.
  • 31.8. Tecan Group Ltd.
  • 31.9. BGI Genomics Co. Ltd.
  • 31.10. Promega Corporation
  • 31.11. 10x Genomics Inc.
  • 31.12. Takara Bio Inc.
  • 31.13. NanoString Technologies Inc.
  • 31.14. Vizgen
  • 31.15. HiFiBiO Therapeutics

32. Global Single-Cell Omics Market Competitive Benchmarking

33. Global Single-Cell Omics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Single-Cell Omics Market

35. Single-Cell Omics Market Future Outlook and Potential Analysis

  • 35.1 Single-Cell Omics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Single-Cell Omics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Single-Cell Omics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer